We compared MRI criteria used 
Introduction
Multiple sclerosis ultimately is a histopathological diagnosis, and clinical criteria have been developed for the diagnosis of multiple sclerosis during life. Clinical criteria essentially require fulfilment of two prerequisites, i.e. dissociation of the disease progress in time and in space (Schumacher et al., 1965) . In the most recent and commonly applied clinical criteria (Poser et al., 1983) , paraclinical evidence can be used in making a diagnosis of clinically definite or laboratory supported definite multiple sclerosis. Paraclinical support for multiple sclerosis can consist of abnormalities detected with Paty et al. (Neurology 1988; 38: 180-5 ) and of Fazekas et al. (Neurology 1988; 38: 1822-5) . We concluded that a four-parameter dichotomized MRI model including gadolinium-enhancement, juxtacortical, infratentorial and periventricular lesions best predicts conversion to clinically definite multiple sclerosis. evoked potentials, cerebrospinal fluid analysis, or imaging techniques (Poser et al., 1983) . The most sensitive paraclinical test is MRI, showing abnormalities in~95% of patients with clinically definite multiple sclerosis (Paty et al., 1988) . As with any medical test showing a high sensitivity, the specificity (in this context conversion from suspected to clinically definite multiple sclerosis) of MRI for multiple sclerosis is usually considerably lower, reaching 57% after a follow-up of 2 years (Lee et al., 1991) . Likewise, based on a 5-year follow-up study, the positive predictive value (PPV) (Paty et al., 1988) of which 1 is periventricular * at first presentation
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of an abnormal brain MRI scan (minimum four lesions) in patients presenting with isolated syndromes suspected of multiple sclerosis is 65%, while the negative predictive value (NPV) of a normal brain MRI scan at presentation is 97% (Morissey et al., 1993) . Since comparable MRI abnormalities may be found in a variety of other diseases and in healthy volunteers, criteria have been developed by which MRIs can be classified as suggestive of multiple sclerosis or not. Initially, studies relied on the presence of more than three lesions Ͼ3 mm (Gebrarski et al., 1985) , sometimes reinforced by the presence of a 'lumpy-bumpy' periventricular border (Runge et al., 1984) . Those features were later incorporated by Paty et al. (1988) into the MRI criteria now commonly used (Table 1) . The criteria of Paty have been evaluated prospectively in patients presenting with isolated syndromes suggestive of multiple sclerosis, showing high sensitivity but relatively low specificity (Paty et al., 1988; Lee et al., 1991) . Several other diagnostic criteria have been proposed (Table 1) , of which the most extensively used ones are those by Fazekas et al. (1988) . In a retrospective study of patients with established multiple sclerosis, the criteria of Fazekas showed both high sensitivity and a high specificity (Offenbacher et al., 1993) , but the criteria of Fazekas et al. (1988) perform less well in a prospective fashion when applied to patients presenting with an isolated syndrome suggestive of multiple sclerosis (Tas et al., 1995) .
The typical MRI findings in multiple sclerosis are a reflection of the histopathology of the disease. The periventricular location, especially in the corpus callosum, and the characteristic ovoid nature of the lesions with extensions (Dawson fingers) into the adjacent white matter (Dawson, 1916) are dictated by the perivenular distribution of multiple sclerosis plaques (Fog, 1965) . It is therefore not surprising that the criteria of both Paty and Fazekas incorporate periventricular lesions (Fazekas et al., 1988; Paty et al., 1988) , and that ovoid and callosal/subcallosal MRI abnormalities are a frequent finding (Simon et al., 1986; Horowitz et al., 1989; Gean-Marton et al., 1991) . However, the reason for choosing certain MRI parameters to be used as diagnostic criteria is not always explicitly described (Fazekas et al., 1988; Paty et al., 1988) . Only one study (Namer et al., 1993) addressed the relative significance of various MRI findings using a multiple linear regression analysis; they found that temporal and occipital lesions were good predictors of multiple sclerosis. However, this study was carried out in patients with established multiple sclerosis, and the results can not be simply applied to patients presenting with a first symptom of what might become multiple sclerosis.
Gadolinium-enhancement depicts the early inflammatory phase of multiple sclerosis lesions (Grossman et al., 1986; Katz et al., 1990; Nesbit et al., 1991) . It has therefore been speculated that presence of both enhancing and non-enhancing MRI lesions is the radiological counterpart of dissociation in space and in time (Heun et al., 1988) . One study (Tas et al., 1995) showed that gadolinium-enhancement was more specific for diagnosing multiple sclerosis than abnormalities revealed on T 2 -weighted imaging. In that study gadoliniumenhancement was compared with the composite criteria of Paty and Fazekas, but not with other individual diagnostic MRI criteria.
The purpose of the present study was to evaluate the importance of several individual brain MRI criteria at first presentation to predict the conversion to clinically definite multiple sclerosis. We combine data from three groups of patients with isolated syndromes suggestive of multiple sclerosis who were studied prospectively for a minimum of 2 years. We aimed to compare individual MRI criteria, including gadolinium-enhancement, in patients followed from the onset of symptoms, to determine up-to-date criteria with high predictive value for conversion to clinically definite multiple sclerosis.
Patients and methods
Patients with clinically isolated syndromes suggestive of multiple sclerosis which could not be attributed to other diseases had been identified prospectively in three centres. In Amsterdam, 42 patients with a variety of symptomatology suggestive of multiple sclerosis were identified during a 12-month period in 1992 by alerting neurologists and ophthalmologists in neighbouring hospitals. The patients are part of a larger cohort (n ϭ 59), of which the early findings have been previously reported (Tas et al., 1995) . Of the original cohort, seven patients were lost to followup, while 10 patients were subsequently given a definitive diagnosis other than multiple sclerosis and were excluded from the present analysis. In Milan, 19 patients were identified mainly with spinal cord symptomatology in 1992-3; the early findings of some of these have been reported on previously (Campi et al., 1995) . In London, 13 patients with optic neuritis had been identified in 1986-90 from the Physicians Unit at Moorfields' Eye Hospital; the early findings on some of those have been reported previously (Youl et al., 1991) . In Milan and London, patients with diagnoses other than multiple sclerosis had been excluded already in earlier reports.
The follow-up period was extended beyond that reported previously, and all patients were reassessed for the occurrence of new symptoms. This was done by a single neurologist at each centre, who personally reviewed all available medical data and contacted patients when insufficient clinical data were documented. Clinically definite multiple sclerosis was diagnosed when new symptoms or signs had occurred in other parts of the central nervous system, after an interval of at least 1 month (Poser et al., 1983) , and when other diagnoses had been ruled out by appropriate tests, such as serological testing or spinal cord imaging, according to local standards. MRI (and other paraclinical evidence) was not used in the final assessment of the diagnosis of clinically definite multiple sclerosis.
MRI was performed at 0.6 T in Amsterdam (Technicare, Solon, Ohio, USA), at 1.5 T in Milan (Siemens SP63 and GBS III, Erlangen, Germany) and at 0.5 T in London (Picker, Cleveland, Ohio, USA). In all three centres the scanning protocol included axial slices through the brain with a 192 ϫ 256 or 256 ϫ 256 pixel matrix, and included double echo T 2 -weighted spin-echo images and T 1 -weighted spin-echo images after intravenous injection of 0.1 mmol/kg gadolinium-DTPA. The slice thickness was 5 mm (1.25-mm gap) in Amsterdam, 6 mm (1.2-mm gap) in Milan and 5 or 10 mm (contiguous) in London.
The MRIs were analysed by consensus during a single session by two observers (F.B. and M.F.) who were unaware of the clinical findings. From the T 2 -weighted images the following items were scored: number of frontal, parietal, temporal, occipital, infratentorial, basal ganglia (including internal capsule) and total number of T 2 lesions; number of periventricular lesions, number of callosal/subcallosal lesions, number of juxtacortical (contiguous with the cortex) lesions, number of lesions Ͼ6 mm, and the presence/absence of at least one ovoid lesion. The gadolinium-enhanced T 1 -weighted images were analysed for the number of enhancing lesions, the number of enhancing lesions Ͼ6 mm and the number of hypointense lesions. Typical examples are presented in Figs 1-4. Based on a combination of imaging findings, patients were classified as not compatible with multiple sclerosis, or compatible with multiple sclerosis, according to the criteria of Paty and Fazekas (Figs 2 and 4; Table 1 ).
Based on the clinical outcome at follow-up (multiple sclerosis or not multiple sclerosis) the imaging findings were classified as true positive (TP, test abnormal and diagnosis multiple sclerosis), true negative (TN, test normal, no multiple sclerosis), false positive (FP, test abnormal, no multiple sclerosis), or false negative (FN, test normal, but diagnosis multiple sclerosis). Sensitivity was determined by the ratio TP/(TP ϩ FN); specificity by TN/(TN ϩ FP); and accuracy by (TP ϩ TN)/(TP ϩ TN ϩ FP ϩ FN). PPV was defined as TP/(TP ϩ FP), NPV as TN/(TN ϩ FN). Logistic regression analysis was performed to assess the relative contribution of the individual imaging parameters (all MRI parameters considered as independents) in predicting the diagnosis at follow-up (dependent). Both forward and backward stepwise analyses were conducted (using Wald's statistic as a criterion), with a P-value for entry of 0.05, and a P-value for removal of 0.1 (Altman et al., 1991) . Based on these findings several MRI criteria were selected, and a regression model was built with these terms to predict the diagnosis and calculate the chance of having clinically definite multiple sclerosis with any combination of these parameters. This was done after the continuous parameters were dichotomized according to maximum accuracy to determine the best cut-off point for that particular parameter using ROC (receiver operating characteristic) curves (curves not shown).
Results
At the time of the MRI, the duration of symptoms varied from 1 to 20 weeks, with a median of 4 weeks. The presenting symptoms of the patients are detailed in Table 2 . During follow-up, clinically definite multiple sclerosis was diagnosed in 33 patients (prevalence 45%) after a median period of 9 months (range 1-48, interquartile range 5.5-23 months). Multiple sclerosis had not been diagnosed in the remaining 41 patients after a median follow-up of 39 months (range 23-96 months). Figure 5 displays the cumulative percentage of patients converting to clinically definite multiple sclerosis over the duration of the follow-up. The MRI scan showed no abnormalities in 13 patients, of whom only one developed clinically definite multiple sclerosis (NPV 92%). T 2 abnormalities were found in the remaining 61 patients (range 1-145, median 4.5 lesions). In those patients converting to clinically definite multiple sclerosis, the shows four hyperintense lesions, three of which display an ovoid shape. The two lesions that enhance with gadolinium on the T 1 -weighted image (B) are in a callosal/subcallosal location, while one of the non-enhancing lesions is located around the border of the left lateral ventricle and is Ͼ6 mm in diameter. Note that the right-sided non-enhancing lesion has a hypointense appearance in B. The presence of four lesions, with one being periventricularly located fulfils the criteria of Paty et al. (1988) . median number of lesions was 16 (in patients without conversion, the median was 2). Using the continuous MRI parameters, the forward stepwise method revealed significant contributions from only gadolinium-enhancement (coefficient, B ϭ 0.96; standard error, SE ϭ 0.36; P ϭ 0.0081) and juxta-cortical lesions (B ϭ 0.49; SE ϭ 0.23; P ϭ 0.028). Although the criterion of oval lesions was initially included in the first step of the analysis, it was removed later when gadolinium-enhancement had been added. The backward method confirmed that gadolinium-enhancement and juxtacortical lesions provided the most important information, and, in addition, revealed (less) significant contributions from periventricular lesions, hypointense T 1 lesions, infratentorial lesions, large enhancing lesions, and the total number of T 2 lesions. Several parameters, including the total number of T 2 lesions had negative B-values; since adding such parameters with negative prediction is confusing, only parameters with positive Bvalues are considered interesting. Following gadoliniumenhancement and juxtacortical lesions, the strongest positive B-values were found for infratentorial and periventricular lesions, which have also been included in other diagnostic criteria (Fazekas et al., 1988) .
Although the presence of any T 2 abnormality provided high sensitivity for conversion to clinically definite multiple sclerosis, specificity was poor. By increasing the minimum number of lesions in order to classify a scan as abnormal, specificity increased, while sensitivity decreased (Fig. 6) . Accuracy was found to be optimal at a minimum of nine T 2 lesions. Similar curves were also constructed for al the other continuous MRI criteria (graphs not shown); following the optimization of cut-off points, prevalence, PPV, sensitivity, specificity and accuracy were determined (Table 3) .
Based on the results of the logistic regression analysis, four dichotomized MRI parameters (gadolinium-enhancement, infratentorial, juxtacortical and periventricular lesions) Fig. 5 Cumulative percentage of patients converting to clinically definite multiple sclerosis. Note that one dot can represent more than one patient, and that the rate of accumulation flattens off after 2 years (median time to conversion 9 months).
Fig. 6
Curves of sensitivity and specificity versus the total number of hyperintense lesions on T 2 -weighted images. With an increasing number of lesions required to classify a scan as abnormal sensitivity (dashed line) decreases, while specificity (solid line) increases. The fact that accuracy is optimal at a minimum of nine lesions, and not at the intercept of the two lines between seven and eight, is related to the fact that the prevalence is Ͼ50%.
were used to build a final regression model, which had a sensitivity of 82%, a specificity of 78%, and an accuracy of 80%. Using this model (PPV 75%, NPV 84%), the chance of developing multiple sclerosis during the follow-up period was calculated for each individual patient, and the effect of the number of abnormal parameters on calculated risk and observed outcome is shown in Table 4 . The predicted chance of converting to clinically definite multiple sclerosis based on the model fitted well with the clinical outcome (goodnessof-fit 75.96).
Discussion
In this study we investigated the relative contribution of several MRI criteria derived from T 2 -weighted and gadolinium-enhanced T 1 -weighted images in making a diagnosis of multiple sclerosis in a large cohort of patients presenting with a first episode of symptoms suggestive of multiple sclerosis. The 'gold standard' in the present study was conversion to clinically definite multiple sclerosis. In autopsy studies, the diagnosis of multiple sclerosis is supported by neuropathological findings in~95% of cases, and can be considered as a reliable reference (Herndon and Brooks, 1985) . One might argue that with longer follow-up the rate of conversion to clinically definite multiple sclerosis will increase and the diagnostic performance of the paraclinical test will change. In this study, the median duration of follow-up in those patients who had not converted to clinically definite multiple sclerosis (39 months) was relatively long in comparison with the median duration of the time to conversion to clinically definite multiple sclerosis in those patients that did convert (9 months). Of those patients who converted to clinically definite multiple sclerosis, 50% had done so by 9 months, while 90% had done so by 30 months of follow-up. Figure 5 suggests that the results of the present study are not likely to change dramatically with longer periods of follow-up. As in many other studies, the prevalence of multiple sclerosis at follow-up was lower than 50%, which determines that specificity is more important than sensitivity. The stepwise logistic regression analysis therefore identifies as the most significant predictors gadolinium-enhancement and juxtacortical lesions, both of which are relatively specific (and prevalent).
The currently most commonly used diagnostic MRI criteria for multiple sclerosis are those by Paty et al. (1988) (Table  1) , which were established in a prospective study. Our results confirm that those criteria are quite sensitive, but not very specific (Table 3) . We found that the diagnostic accuracy would increase from 69 to 80% by requiring a minimum of nine lesions instead of four, as in the criteria of Paty. Interestingly, this number approximates with the number of 'average sized' lesions making up the area of 1.23 cm 2 , which was the cut-off point in a study which investigated the minimum area predicting future disability in patients with isolated syndromes suggestive of multiple sclerosis (Filippi et al., 1994) . Completely normal brain MRI scans were acquired in a low percentage of cases (18%) and, as in previous studies (Filippi et al., 1994) , had a very high NPV. It should be noted that a negative brain MRI does not rule out definitively the diagnosis of multiple sclerosis, which is ultimately made on clinical grounds. Recently, Thorpe et al. (1996) described a series of 20 patients with suspected multiple sclerosis with a negative brain scan, in whom MRI of the spinal cord revealed lesions in all of them, suggesting that spinal imaging further increases sensitivity and NPV.
In order to increase specificity, Fazekas et al. (1988) developed composite criteria (Table 1) which showed high specificity in two retrospective studies involving patients with established multiple sclerosis compared with patients with other neurological diseases (Fazekas et al., 1988; Offenbacher et al., 1993) . In this prospective study of cases See text for optimization of cut-off points. CDMS ϭ clinically definite multiple sclerosis; PPV ϭ positive predictive value; NA ϭ not applicable. et al. (1988) and Fazekas et al. (1988) . PPV ϭ positive predictive value; NPV ϭ negative predictive value.
with clinically isolated syndromes suggestive of multiple sclerosis, such criteria do not perform as well (sensitivity 88%; specificity 54%), underlining the need of testing criteria in a prospective fashion. For the individual elements making up the criteria of Fazekas, the optimum cut-off point is not always just simply 1, but 2 for lesions Ͼ6 mm, and 3 for periventricular lesions. By taking these cut-off points, each of the elements making up the Fazekas criteria had an accuracy equal to or better than the composite measure (Table  3 ). The same holds true for the criteria of Paty, i.e. the optimized individual elements perform better than the composite measure they lead up to (Table 3) . In fact, it is more realistic to assess the number of lesions and apply the corresponding sensitivity/specificity (Fig. 6) . Likewise, one can better predict the chance of developing clinically definite multiple sclerosis based on the number of abnormal MRI criteria, than to be forced to make a two-choice decision (compatible with multiple sclerosis or not). Many of the individual MRI criteria show reasonably high accuracy once the cut-off point is optimized (Table 3) , which already indicates that the various parameters must be strongly associated. Logistic regression analysis was therefore used to reduce redundancy in information and to identify those parameters best predicting conversion to clinically definite multiple sclerosis. The forward stepwise method (which is the most strict) revealed juxtacortical and enhancing lesions as the only significant contributors. Using a backwards analysis (which is less rigid) a more complex model was found with a higher accuracy, but several MRI parameters were assigned negative B-values; this indicates that in the presence of several other good predictors, an increasing number of T 2 lesions now harbours an NPV, indicating a tendency for over fitting. The backwards analysis, however, confirms the relevance of enhancing and juxtacortical lesions and, in addition, reveals significant contributions from (amongst others) infratentorial and periventricular lesions. Since the latter two have been considered to be relevant in multiple sclerosis in many studies already, they were included in our final model. This model has an overall accuracy of 80% and the predictive value of the cumulative number of criteria being positive correlates very closely with final outcome (Table 4) , illustrating an appropriate fit to the data. The simplicity of using only four variables in a dichotomized fashion is attractive, since they can be quickly assessed, and the number of criteria being positive translated into a chance of developing multiple sclerosis is much more realistic than a forced yes-or-no answer.
Interestingly, our final model does not include the total number of lesions any more. This result coincides with the common-sense that it is not merely the number of lesions that counts, but rather (i) what sort of lesions are found and (ii) where they are found. Periventricular lesions (Fig. 2) were implicated early on (Runge et al., 1984) , and were incorporated in the criteria of both Paty et al. (1988) and Fazekas et al. (1988) . It relates to the fact that multiple sclerosis lesions are located around venules, with the majority of medullary veins draining into the subependymal veins in the lateral ventricles (Dawson, 1916) . Infratentorial lesions (Fig. 4) were incorporated into the criteria of Fazekas. Apparently multiple sclerosis lesions occur throughout the brain, while lesions occurring in other diseases tend to be confined more frequently to the supratentorial compartment, although this is not universally true: sarcoid (Sherman and Stern, 1990) , acute disseminated encephalomyelopathy (Caldemeyer et al., 1994 ), Behçet's disease (Kazui et al., 1991) , systemic lupus erythemathosis (Miller et al., 1987) , and many other diseases may all produce brainstem lesions. Lesion in the cortex (Fig. 1 ) make up a substantial percentage of lesions in histopathological studies, up to 59% in one series (Lumsden, 1970) . Using fluid attenuated inversion recovery (FLAIR), the percentage of juxtacortical lesions in multiple sclerosis was 30% (Filippi et al., 1995) . Their presence is related to myelinated axons extending well into the cortex, and contrasts with hypoxic/ischaemic diseases where the direct subcortical zone, containing the U-fibres, is typically spared (van der Knaap and Valk, 1995) . Not included in our model was the presence of callosal/subcallosal lesions. Their significance has been stressed by several authors (Simon et al., 1986; Gean-Marton et al., 1991) , but their prevalence at first presentation has not been studied. Apparently their presence does not harbour independent information. One can argue that such lesions would be seen to advantage on sagittal images and using FLAIR, both of which were not at our disposal.
In the present study, gadolinium-enhancement (Figs 1 4) was identified as the most predictive MRI parameter. Gadolinium-enhancement reveals a phase of inflammation and active demyelination in experimental allergic encephalomyelitis (Hawkins et al., 1990; Morrissey et al., 1996) and multiple sclerosis (Katz et al., 1990; Nesbit et al., 1991) , and is initially seen in new multiple sclerosis lesions (Grossman et al., 1986; Barkhof et al., 1992) . Kappos et al. (1991) already indicated the value of simultaneous demonstration of enhancing and non-enhancing lesions during a single examination at first presentation. In that series of 14 patients with enhancement, 11 converted to clinically definite multiple sclerosis within 12 months; the PPV in that open study (79%) compares well with the one reported here (75%). Although the final diagnosis remains a clinical one, simultaneous demonstration of enhancing and non-enhancing lesions is the radiological counterpart of clinical dissemination in time and space. In case gadolinium-enhanced images are not available, using the presence of ജ9 T 2 lesions provides an alternative with an accuracy (77%), similar to our final model.
The hypointense lesions that can sometimes be observed on the (gadolinium-enhanced) T 1 -weighted images, have been shown to be more prevalent in multiple sclerosis than in subcortical arteriosclerotic encephalopathy (Uhlenbrock et al., 1989) and to correlate better with changes in disability in more advanced multiple sclerosis (van , but the prevalence of such lesions at first presentation is relatively low (Table 3) , and therefore probably not diagnostically useful.
Recently, 3D fast FLAIR has been used to obtain 1-mm sagittal sections through the brain, revealing many periventricular and subcallosal lesions which went undetected on conventional axial T 2 -weighted sequences (Hashemi et al., 1995) . Perhaps the results of the present analysis would have been different, had this technique been used. The time needed to collect a new sample and obtain the necessary follow-up, precluded such an analysis in the present study. By the same token, the results from such a new study using 3D FLAIR will be challenged by still newer techniques, which almost certainly will be developed within the 5-year period needed to conduct a study like the current one. Currently, however, conventional T 2 -weighted 5-mm axial slices are still widely used, and the results of our study are therefore of considerable practical value. Another potential limitation of our study is the fact that most studies were done at 0.5-T and 0.6-T machines, but the authors of a recent report were unable to confirm the hypothesis that a higher field strength improves the accuracy of MRI in the initial diagnosis of multiple sclerosis (Lee et al., 1995) .
In conclusion, many MRI parameters can be optimized to predict conversion to clinically definite multiple sclerosis at first presentation. Our study shows that the diagnostic performance of such criteria are best tested in a prospective fashion in patients with isolated clinical syndromes. Our results indicate that gadolinium-enhancement and juxtacortical lesions are the most relevant MRI criteria. Adding infratentorial and periventricular lesions increases the number of abnormal criteria to creating a simple model with increased probability of developing multiple sclerosis. The use of only four dichotomized variables ensures that the model can be applied easily in daily practice, and that the PPV can be inferred from the number of abnormal criteria in a straight forward fashion (Table 4 ). The fact that this model has a higher specificity (and PPV) than other currently available criteria is fortunate, at a time when the introduction of more effective therapies require the emphasis to be shifted, from excluding multiple sclerosis, towards predicting the development of multiple sclerosis (Table 5) .
